174 related articles for article (PubMed ID: 30927240)
21. Surgical Management of Familial Papillary Thyroid Microcarcinoma: A Single Institution Study of 94 Cases.
Sung TY; Lee YM; Yoon JH; Chung KW; Hong SJ
World J Surg; 2015 Aug; 39(8):1930-5. PubMed ID: 25894401
[TBL] [Abstract][Full Text] [Related]
22. Predictors of incomplete response to therapy among Filipino patients with papillary thyroid cancer in a tertiary hospital.
Mendoza ES; Lopez AA; Valdez VA; Cunanan EC; Matawaran BJ; Kho SA; Sero-Gomez MH
J Endocrinol Invest; 2016 Jan; 39(1):55-62. PubMed ID: 26036600
[TBL] [Abstract][Full Text] [Related]
23. Familial Papillary Thyroid Carcinoma (FPTC): a Retrospective Analysis in a Sample of the Bulgarian Population for a 10-Year Period.
Vidinov K; Nikolova D
Endocr Pathol; 2017 Mar; 28(1):54-59. PubMed ID: 27771834
[TBL] [Abstract][Full Text] [Related]
24. Age greater than 60 years portends a worse prognosis in patients with papillary thyroid cancer: should there be three age categories for staging?
Kauffmann RM; Hamner JB; Ituarte PHG; Yim JH
BMC Cancer; 2018 Mar; 18(1):316. PubMed ID: 29566662
[TBL] [Abstract][Full Text] [Related]
25. [Follicular cell (papillary and follicular) thyroid carcinoma, genetic inheritance, and molecular diagnostic markers].
Kazubskaia TP; Kozlova VM; Kondrat'eva TT; Pavlovskaia AI; Marakhonov AV; Baranova AV; Ivanova NI; Stepanova AA; Poliakov AV; Belev NF; Brzhezovskiĭ VZh
Arkh Patol; 2014; 76(5):3-12. PubMed ID: 25543402
[TBL] [Abstract][Full Text] [Related]
26. Incidental papillary thyroid carcinoma: clinical characteristics and prognostic factors among patients with Graves' disease and euthyroid goiter, Cleveland Clinic experience.
Ergin AB; Saralaya S; Olansky L
Am J Otolaryngol; 2014; 35(6):784-90. PubMed ID: 25128909
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.
Sabet A; Binse I; Grafe H; Ezziddin S; Görges R; Poeppel TD; Bockisch A; Rosenbaum-Krumme SJ
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1988-94. PubMed ID: 27118127
[TBL] [Abstract][Full Text] [Related]
28. [Related factors of high-volume lymph node metastasis in multifocal papillary thyroid carcinoma].
Hu CF; Zhang T; Wei PY; Cao HJ; Han ZJ
Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(40):3199-3203. PubMed ID: 37879874
[No Abstract] [Full Text] [Related]
29. Multifocality as independent prognostic factor in papillary thyroid cancer - A multivariate analysis.
Markovic I; Goran M; Besic N; Buta M; Djurisic I; Stojiljkovic D; Zegarac M; Pupic G; Inic Z; Dzodic R
J BUON; 2018; 23(4):1049-1054. PubMed ID: 30358210
[TBL] [Abstract][Full Text] [Related]
30. Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma.
Lee YM; Yoon JH; Yi O; Sung TY; Chung KW; Kim WB; Hong SJ
J Surg Oncol; 2014 Feb; 109(2):168-73. PubMed ID: 24132694
[TBL] [Abstract][Full Text] [Related]
31. Familial papillary thyroid microcarcinoma: a new clinical entity.
Lupoli G; Vitale G; Caraglia M; Fittipaldi MR; Abbruzzese A; Tagliaferri P; Bianco AR
Lancet; 1999 Feb; 353(9153):637-9. PubMed ID: 10030330
[TBL] [Abstract][Full Text] [Related]
32. Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study.
Kim M; Kim HK; Kim HI; Kim EH; Jeon MJ; Yi HS; Kim ES; Kim H; Kim TH; Kim BH; Kim TY; Kang HC; Kim WB; Chung JH; Shong YK; Kim SW; Kim WG
Oral Oncol; 2018 Nov; 86():48-52. PubMed ID: 30409319
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of young age in papillary thyroid carcinoma: analysis of 5,733 patients with 150 months' median follow-up.
Ito Y; Miyauchi A; Kihara M; Higashiyama T; Kobayashi K; Miya A
Endocr J; 2014; 61(5):491-7. PubMed ID: 24553476
[TBL] [Abstract][Full Text] [Related]
34. Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment.
Musholt TJ; Musholt PB; Petrich T; Oetting G; Knapp WH; Klempnauer J
World J Surg; 2000 Nov; 24(11):1409-17. PubMed ID: 11038215
[TBL] [Abstract][Full Text] [Related]
35. Is Familial Nonmedullary Thyroid Cancer A More Aggressive Type of Thyroid Cancer?
Muallem Kalmovich L; Jabarin B; Koren S; Or K; Marcus E; Tkacheva I; Benbassat C; Steinschneider M
Laryngoscope; 2021 Feb; 131(2):E677-E681. PubMed ID: 32761812
[TBL] [Abstract][Full Text] [Related]
36. A new method for segmentation of FDG PET metabolic tumour volume using the peritumoural halo layer and a 10-step colour scale. A study in patients with papillary thyroid carcinoma.
Jun S; Kim H; Nam HY
Nuklearmedizin; 2015; 54(6):272-85. PubMed ID: 26429587
[TBL] [Abstract][Full Text] [Related]
37. Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer.
Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
Medicine (Baltimore); 2018 Dec; 97(51):e13435. PubMed ID: 30572443
[TBL] [Abstract][Full Text] [Related]
38. Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor.
Castagna MG; Forleo R; Maino F; Fralassi N; Barbato F; Palmitesta P; Pilli T; Capezzone M; Brilli L; Ciuoli C; Cantara S; Formichi C; Pacini F
J Endocrinol Invest; 2018 Sep; 41(9):1029-1035. PubMed ID: 29470826
[TBL] [Abstract][Full Text] [Related]
39. The role of BRAF(V600E) mutation as poor prognostic factor for the outcome of patients with intrathyroid papillary thyroid carcinoma.
Pelizzo MR; Dobrinja C; Casal Ide E; Zane M; Lora O; Toniato A; Mian C; Barollo S; Izuzquiza M; Guerrini J; De Manzini N; Merante Boschin I; Rubello D
Biomed Pharmacother; 2014 May; 68(4):413-7. PubMed ID: 24721322
[TBL] [Abstract][Full Text] [Related]
40. Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.
Lukas J; Drabek J; Dudesek B; Vazan P; Stranska J; Jancik S; Mackova M; Syrucek M; Lukas D; Duskova J; Dundr P; Hintnausova B; Jiskra J
Exp Clin Endocrinol Diabetes; 2014 May; 122(5):268-72. PubMed ID: 24839220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]